End Cash: The amount of cash held by the company for the given period.
Intensity Therapeutics Inc. (INTS) had End Cash of $11.92M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-11.61M |
|
-- |
|
-- |
|
$11.97M |
|
$-11.97M |
|
$0.37M |
|
$-11.61M |
|
$-11.61M |
|
$-11.61M |
|
$-11.61M |
|
$-11.61M |
|
$-11.61M |
|
$-11.97M |
|
$-11.95M |
|
1.36M |
|
1.36M |
|
$-8.56 |
|
$-8.56 |
|
| Balance Sheet Financials | |
$12.71M |
|
-- |
|
$1.39M |
|
$14.10M |
|
$2.15M |
|
$0.08M |
|
$0.08M |
|
$2.23M |
|
$11.88M |
|
$11.88M |
|
$11.88M |
|
2.52M |
|
| Cash Flow Statement Financials | |
$-9.23M |
|
$0.00M |
|
$18.56M |
|
$2.59M |
|
|
End Cash |
$11.92M |
$9.33M |
|
$2.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.92 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.23M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-97.73% |
|
-97.73% |
|
-82.31% |
|
-97.08% |
|
$4.71 |
|
$-6.81 |
|
$-6.81 |
|